Information Provided By: 
Fly News Breaks for February 28, 2020
TRHC
Feb 28, 2020 | 06:00 EDT
Piper Sandler analyst Sean Wieland raised the firm's price target on Tabula Rasa HealthCare to $72 from $66. The company reported Q4 revenue and adjusted EBITDA that were in line and offered 2020 guidance that implies ~20% top-line growth and improving profitability, Wieland tells investors in a research note. The analyst believes "clear communication and consistent execution" will earn Tabula the multiple expansion his price target implies.
News For TRHC From the Last 2 Days
There are no results for your query TRHC
